Prelude Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Prelude Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Prelude Therapeutics Inc
Rating: 1.57275
Author: Trendlyne DVM scores

about

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes ...

0.82 -0.07 (-7.87%)

87.94% Fall from 52W High

161.9K

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

23.0 / 100

Technically Neutral

39.9 / 100

1Yr Price target upside is 357%

4 analysts

Prelude Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Prelude Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes ...

87.94% Fall from 52W High

SWOT Analysis

Prelude Therapeutics Inc Live Price Chart